91AV

Introduction

Across three days, this meeting will unite 200+ leading experts from gene therapeutic industries including biotech, pharma, academic, and govt. organizations from around the world delivering actionable insights and valuable networking opportunities to accelerate gene therapy progress.

Deadlines

• Aug 26 2022
  Early bird registration deadline

  
• Jan 31 2023
  Oral abstracts deadline

  
• Jan 31 2023
  Poster abstract deadline

  
• Mar 31 2023
  Standard registration deadline

  

Useful links

Downloads

• Agenda

Speakers

• Angela Columbano Head Business Development and Partnership, Genethon
  , France
• Elie Hanania Vice President, Process Development Viral Vector Technologie, United States
• Deirdre E. Sanders Hamilton, Brook, Smith & Reynolds, United States
• Michele Stone Chief Scientific Officer, Kriya Therapeutics, United States
• Daniel Kavanagh Senior Scientific Advisor, Gene Therapy, United States
• Charlene Son Rigby CEO, RARE-X, United States
• Jeff Gilmore Chief Executive Officer, cGMPNow, CO, United States
• Colin Dinney Department Chairman, Department of Urology, UT MD Anderson, United States

---

Venue

Hilton Boston Logan Airport

Hilton Boston Logan Airport, Boston Logan Airport, Boston, 02128, United States

Committee

• Michael Fossel President and Founder, Telocyte, United States
• Rajesh B. Shukla Senior Medical Director, SSI Strategy, United States

---

Contact information

Sachin Sravan
Biogate Scientific Center
9160331607
Contact us by email

---